Literature DB >> 16267366

Proteinases and oxidants as targets in the treatment of chronic obstructive pulmonary disease.

Caroline A Owen1.   

Abstract

There is now compelling evidence that proteinases and oxidative stress play pathogenetic roles in the following pathologies in chronic obstructive pulmonary disease: airspace enlargement; chronic inflammation in the airways, lung interstitium, and alveolar space; and mucus hypersecretion in the large airways. Proteinases and oxidants may also contribute to remodeling processes in the small airways. In addition, data are emerging that show interactions between classes of proteinases and between proteinases and oxidants, which amplify lung inflammation and injury in chronic obstructive pulmonary disease. This review discusses the biologic roles of proteinases and oxidants, their roles in the pathogenesis of chronic obstructive pulmonary disease, and their potential as targets for therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16267366      PMCID: PMC2713328          DOI: 10.1513/pats.200504-029SR

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  153 in total

1.  Nacystelyn, a novel lysine salt of N-acetylcysteine, to augment cellular antioxidant defence in vitro.

Authors:  A Gillissen; M Jaworska; M Orth; M Coffiner; P Maes; E M App; A M Cantin; G Schultze-Werninghaus
Journal:  Respir Med       Date:  1997-03       Impact factor: 3.415

Review 2.  Role of transcription factors in inflammatory lung diseases.

Authors:  I Rahman; W MacNee
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

3.  Increased content of hydrogen peroxide in the expired breath of cigarette smokers.

Authors:  D Nowak; A Antczak; M Krol; T Pietras; B Shariati; P Bialasiewicz; K Jeczkowski; P Kula
Journal:  Eur Respir J       Date:  1996-04       Impact factor: 16.671

4.  Effects of exogenous vitamin E supplementation on the levels of oxidants and antioxidants in chronic obstructive pulmonary disease.

Authors:  M K Daga; Rashmi Chhabra; Bhavneesh Sharma; T K Mishra
Journal:  J Biosci       Date:  2003-02       Impact factor: 1.826

5.  Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage.

Authors:  J D Morrow; B Frei; A W Longmire; J M Gaziano; S M Lynch; Y Shyr; W E Strauss; J A Oates; L J Roberts
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

6.  Alterations in leukocyte oxidative metabolism in cigarette smokers.

Authors:  P W Ludwig; J R Hoidal
Journal:  Am Rev Respir Dis       Date:  1982-12

7.  Clinical evaluation of acetylcysteine in the treatment of patients with chronic obstructive bronchitis: a balanced double-blind trial with placebo control.

Authors:  M Aylward; J Maddock; P Dewland
Journal:  Eur J Respir Dis Suppl       Date:  1980

8.  Release of interleukin-8, interleukin-6, and colony-stimulating factors by upper airway epithelial cells: implications for cystic fibrosis.

Authors:  M Bédard; C D McClure; N L Schiller; C Francoeur; A Cantin; M Denis
Journal:  Am J Respir Cell Mol Biol       Date:  1993-10       Impact factor: 6.914

9.  Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema.

Authors:  J D'Armiento; S S Dalal; Y Okada; R A Berg; K Chada
Journal:  Cell       Date:  1992-12-11       Impact factor: 41.582

10.  Alpha 1-proteinase inhibitor is a neutrophil chemoattractant after proteolytic inactivation by macrophage elastase.

Authors:  M J Banda; A G Rice; G L Griffin; R M Senior
Journal:  J Biol Chem       Date:  1988-03-25       Impact factor: 5.157

View more
  35 in total

Review 1.  The Beneficial Effects of Antioxidants in Health And Diseases.

Authors:  Sabina Janciauskiene
Journal:  Chronic Obstr Pulm Dis       Date:  2020-07

Review 2.  Airway mucus: From production to secretion.

Authors:  Olatunji W Williams; Amir Sharafkhaneh; Victor Kim; Burton F Dickey; Christopher M Evans
Journal:  Am J Respir Cell Mol Biol       Date:  2006-01-13       Impact factor: 6.914

Review 3.  Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted.

Authors:  Kendra J Greenlee; Zena Werb; Farrah Kheradmand
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

Review 4.  The stumbling block in lung repair of emphysema: elastic fiber assembly.

Authors:  Adrian Shifren; Robert P Mecham
Journal:  Proc Am Thorac Soc       Date:  2006-07

Review 5.  HBOC vasoactivity: interplay between nitric oxide scavenging and capacity to generate bioactive nitric oxide species.

Authors:  Pedro Cabrales; Joel M Friedman
Journal:  Antioxid Redox Signal       Date:  2013-02-12       Impact factor: 8.401

6.  Toll-like receptor 4 deficiency causes pulmonary emphysema.

Authors:  Xuchen Zhang; Peiying Shan; Ge Jiang; Lauren Cohn; Patty J Lee
Journal:  J Clin Invest       Date:  2006-10-19       Impact factor: 14.808

7.  The presence of a matrix-derived neutrophil chemoattractant in bronchiolitis obliterans syndrome after lung transplantation.

Authors:  Matthew T Hardison; F Shawn Galin; Christopher E Calderon; Uros V Djekic; Suzanne B Parker; Keith M Wille; Patricia L Jackson; Robert A Oster; K Randall Young; J Edwin Blalock; Amit Gaggar
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

8.  Hhip haploinsufficiency sensitizes mice to age-related emphysema.

Authors:  Taotao Lao; Zhiqiang Jiang; Jeong Yun; Weiliang Qiu; Feng Guo; Chunfang Huang; John Dominic Mancini; Kushagra Gupta; Maria E Laucho-Contreras; Zun Zar Chi Naing; Li Zhang; Mark A Perrella; Caroline A Owen; Edwin K Silverman; Xiaobo Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-21       Impact factor: 11.205

Review 9.  Matrix Remodeling in Pulmonary Fibrosis and Emphysema.

Authors:  Tejaswini Kulkarni; Philip O'Reilly; Veena B Antony; Amit Gaggar; Victor J Thannickal
Journal:  Am J Respir Cell Mol Biol       Date:  2016-06       Impact factor: 6.914

Review 10.  Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease.

Authors:  Caroline A Owen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.